MBX Biosciences

Biotechnology Research • Carmel, Indiana, United States • 51-100 Employees

Company overview

Headquarters	Carmel, Indiana, United States
Phone number	+13176590200
Website	mbxbio.com
NAICS	541714
Founded	2019
Employees	51-100
Socials

Key Contacts at MBX Biosciences

Jessica Snow

Associate Director, Talent Acquisition

Steve Ryder

Member Board Of Directors

Jim Denike

Senior Director, Investor Relations & Communications

Patricia Carney

Director Clinical Operations

Tyler Carner

Senior Director, Controller

Christi Bruns

Director, Project Management

Stephen Sullivan

Director Of Regulatory Operations

Sarah Lively

Associate Director, Quality Systems

Michael Hackett

Senior Director Of Pharmacology And Toxicology

Chris Kelly

Director, Regulatory Affairs Cmc

MBX Biosciences Email Formats

MBX Biosciences uses 4 email formats. The most common is {first initial}{last name} (e.g., jdoe@mbxbio.com), used 54.7% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@mbxbio.com	54.7%
{first name}{last name}	johndoe@mbxbio.com	35.8%
{last name}{last name}	doedoe@mbxbio.com	7.5%
{first initial}	j@mbxbio.com	1.9%

About MBX Biosciences

MBX Biosciences, Inc. is a clinical stage biopharmaceutical company pioneering investigational Precision Endocrine Peptides (PEPs™). PEPs are designed to overcome key limitations of native peptide therapeutics to deliver superior pharmacologic properties. MBX is advancing a pipeline of PEP candidates to address the unmet needs of people with endocrine disorders. The company’s lead product candidate, MBX 2109 for the treatment of hypoparathyroidism, is currently in a Phase 1 clinical trial. Members of MBX’s leadership team have collaborated over several decades on the discovery, development, and commercialization of highly successful endocrine therapeutics including Forteo® and Humalog®. The company is supported by leading life science investors including Frazier Life Sciences, New Enterprise Associates and OrbiMed.

MBX Biosciences revenue & valuation

Annual revenue	$5,389,965
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$17,300,000
Total funding	$178,500,000

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Director

Entry

Manager

Employees by Department

MBX Biosciences has 39 employees across 10 departments.

Departments

Number of employees

Funding Data

Explore MBX Biosciences's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-12-14	5	$115,000,000
2024-09-05	6	$63,500,000

Funding Insights

$178,500,000

Total funding amount

$63,500,000

Most recent funding amount

Number of funding rounds

MBX Biosciences Tech Stack

Discover the technologies and tools that power MBX Biosciences's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

Vimeo

Video players

Microsoft 365

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

HSTS

Security

PHP

Programming languages

WordPress

Blogs

Bootstrap

UI frameworks

Frequently asked questions

MBX Biosciences is located in Carmel, Indiana, US.

You can reach MBX Biosciences at +13176590200.

MBX Biosciences was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.

MBX Biosciences has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

MBX Biosciences has raised a total of $178,500,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.